Two new investment targets opened in our service this week: Finland’s largest fertility clinic Ovumiaand leading online training software TWID.
Last week’s newcomer Askel Healthcare is a medtech company born as a spin-off from the University of Helsinki. Askel has already raised 41% of its funding goal.
The other case that opened last week, Sharpfin, is a Swedish software startup focused on automating the wealth management industry. Sharpfin has received investments for 72% of its goal.
In events, we have one coming up in Helsinki with analytics house Repo Media. Featured in the event will be Askel Healthcare, Bookwell Digital and Yepzon, and keynote speech will be given by Heeros Oyj founder Pekka Räisänen. Read more and sign up by 14 September.
Ezylet is an exciting property portal aimed at the untapped private rental market. Landlords, Agents & Tenants can access a host of property services all in one place leading to enhanced profits & better customer experience. That’s the Ezylet way!
Sharpfin lives the vision to automate the EUR 80 trillion assets wealth management industry. Invest in one of the most promising B2B Fintech companies with proven business model and growing customer base.
Highly relevant product offering within the asset management industry
Sharpfin has 500 million EUR under management and growing
Clients include, among others, Consensus Asset Management and Privat Consult
TWID: Monthly recurring revenue growth 346% in three years
TWID is the leading online training software in Finland. Our monthly recurring revenue is currently 327.000 euros per year. When it comes to growth, we aim high. Next up are the rest of Scandinavia, the Netherlands and Russia.
MRR is currently 27,265 euros
Customers include e.g. Mika D. Rubanovitsch, Academy of Brain, Lääkärikeskus Aava, The Club Company (UK) and Jana Stewart (USA)
Experienced founding and management team with experience in exits, scaling and international sales
Joint pain? Often the underlying cause is cartilage damage – an unsolved medical issue affecting numerous people and animals. With the COPLA Scaffold™, healing joint surface damage to regain healthy movement is now possible.
Medtech innovation that can solve cartilage-related problems
Years of scientific research experience
Starting sales to veterinarians, later expanding to human patients
Infertility is a growing problem affecting many couples’ dreams of having a child. Ovumia is a leading tech expert in fertility treatments whose customers have had over 12,000 babies. The company is seeking financing for growth through M&As.
Leading fertility clinic chain in North Europe
Estimated revenue for 2017 approximately 4 million euros